- Home
- WDI vs TLRY Comparison
WDI vs TLRY Comparison
Compare WDI & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WDI | TLRY |
|---|---|---|
| Founded | 2021 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 703.9M | 919.2M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | WDI | TLRY |
|---|---|---|
| Price | $13.90 | $6.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $72.33 |
| AVG Volume (30 Days) | 210.4K | ★ 2.7M |
| Earning Date | 01-01-0001 | 04-01-2026 |
| Dividend Yield | ★ 11.80% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.12 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.25 |
| Revenue Next Year | N/A | $16.97 |
| P/E Ratio | $12.37 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.91 | $0.36 |
| 52 Week High | $15.28 | $15.70 |
Technical Indicators
Market Signals| Indicator | WDI | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 65.94 | 52.89 |
| Support Level | $13.60 | $5.89 |
| Resistance Level | $14.10 | $7.01 |
| Average True Range (ATR) | 0.20 | 0.41 |
| MACD | 0.09 | 0.10 |
| Stochastic Oscillator | 98.00 | 89.17 |
Price Performance
Historical ComparisonAbout WDI Western Asset Diversified Income Fund of Beneficial Interest
Western Asset Diversified Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income. As a secondary investment objective, the Fund will seek capital appreciation. The fund seeks to achieve its investment objectives by investing, under normal market conditions, across fixed income sectors and securities in seeking to deliver a well-diversified portfolio.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.